Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Breast (Edinburgh, Scotland)|August 3, 2022
Dual-phase FDG PET/CT for predicting prognosis in operable breast cancerHaruka Ikejiri, Shinsuke Sasada, Akiko Emi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 9, 2021
Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumorsShinsuke Sasada, Yuri Kimura, Norio Masumoto, et al.
Breast Cancer (Tokyo, Japan)|January 12, 2013
Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patientsTatsunari Sasada, Tsuyoshi Kataoka, Hideo Shigematsu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 4, 2018
Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort studyShinsuke Sasada, Norio Masumoto, Noriko Goda, et al.
Clinical Imaging|June 3, 2018
Which type of breast cancers is undetectable on ring-type dedicated breast PET?Shinsuke Sasada, Norio Masumoto, Noriko Goda, et al.
AJR. American Journal of Roentgenology|July 25, 2019
Identification of Axillary Lymph Node Metastasis in Patients With Breast Cancer Using Dual-Phase FDG PET/CTShinsuke Sasada, Norio Masumoto, Yuri Kimura, et al.
Breast Cancer Research and Treatment|February 21, 2015
Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancerKenjiro Aogi, Takayuki Kadoya, Yoshifumi Sugawara, et al.
Breast (Edinburgh, Scotland)|June 13, 2013
Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancerMasahiro Ohara, Hideo Shigematsu, Yasuhiro Tsutani, et al.
Pageof 6